Dunja Mrdjen

Dunja Mrdjen

Auto-generated profile, based on publicly available information

Dunja Mrdjen

Department of Pathology, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2015 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
FMFlorian Mair
Florian Mair
FHFelix J. Hartmann
Felix J. Hartmann
DMDunja Mrdjen
Dunja Mrdjen
VTVinko Tosevski
Vinko Tosevski
CKCarsten Krieg
Carsten Krieg
BBBurkhard Becher
Burkhard Becher

4 January 2019 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SMSarah Mundt
Sarah Mundt
DMDunja Mrdjen
Dunja Mrdjen
SUSebastian G. Utz
Sebastian G. Utz
MGMelanie Greter
Melanie Greter
BSBettina Schreiner
Bettina Schreiner
BBBurkhard Becher
Burkhard Becher
The central nervous system (CNS) is under close surveillance by immune cells, which mediate tissue homeostasis, protection, and repair. Conversely, in neuroinflammation, dysregulated leukocyte invasion into the CNS leads to immunopathology and neurological disability. To invade the brain parenchyma, autoimmune encephalitogenic T helper (TH) cells must encounter their cognate antigens (Ags) presented via local Ag-presenting cells (APCs). The precise identity of the APC that samples, processes, and presents CNS-derived Ags to autoaggressive T cells is unknown. Here, we used a combination of high-dimensional single-cell mapping and conditional MHC class II ablation across all CNS APCs to systematically interrogate each population for its ability to reactivate encephalitogenic TH cells in vivo. We found a population of conventional dendritic cells, but not border-associated macrophages or microglia, to be essential for licensing T cells to initiate neuroinflammation.

22 July 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
EGEdoardo Galli
Edoardo Galli
FHFelix J. Hartmann
Felix J. Hartmann
BSBettina Schreiner
Bettina Schreiner
FIFlorian Ingelfinger
Florian Ingelfinger
EAEirini Arvaniti
Eirini Arvaniti
BBBurkhard Becher
Burkhard Becher

7 August 2019 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
DMDunja Mrdjen
Dunja Mrdjen
EFEdward J. Fox
Edward J. Fox
SBSyed A. Bukhari
Syed A. Bukhari
KMKathleen S. Montine
Kathleen S. Montine
SBSean C. Bendall
Sean C. Bendall
TMThomas J. Montine
Thomas J. Montine

7 November 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
FHFelix J. Hartmann
Felix J. Hartmann
RBRaphaël Bernard-Valnet
Raphaël Bernard-Valnet
CQClémence Quériault
Clémence Quériault
DMDunja Mrdjen
Dunja Mrdjen
LWLukas M. Weber
Lukas M. Weber
BBBurkhard Becher
Burkhard Becher
Narcolepsy type 1 is a devastating neurological sleep disorder resulting from the destruction of orexin-producing neurons in the central nervous system (CNS). Despite its striking association with the HLA-DQB1*06:02 allele, the autoimmune etiology of narcolepsy has remained largely hypothetical. Here, we compared peripheral mononucleated cells from narcolepsy patients with HLA-DQB1*06:02-matched healthy controls using high-dimensional mass cytometry in combination with algorithm-guided data analysis. Narcolepsy patients displayed multifaceted immune activation in CD4+ and CD8+ T cells dominated by elevated levels of B cell–supporting cytokines. Additionally, T cells from narcolepsy patients showed increased production of the proinflammatory cytokines IL-2 and TNF. Although it remains to be established whether these changes are primary to an autoimmune process in narcolepsy or secondary to orexin deficiency, these findings are indicative of inflammatory processes in the pathogenesis of this enigmatic disease.

19 April 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ABAlex Baranski
Alex Baranski
IMIdan Milo
Idan Milo
SGShirley Greenbaum
Shirley Greenbaum
JOJohn Paul Oliveria
John Paul Oliveria
DMDunja Mrdjen
Dunja Mrdjen
LKLeeat Keren
Leeat Keren
Mass Based Imaging (MBI) technologies such as Multiplexed Ion Beam Imaging by time of flight (MIBI-TOF) and Imaging Mass Cytometry (IMC) allow for the simultaneous measurement of the expression levels of 40 or more proteins in biological tissue, providing insight into cellular phenotypes and organization in situ. Imaging artifacts, resulting from the sample, assay or instrumentation complicate downstream analyses and require correction by domain experts. Here, we present MBI Analysis User Interface (MAUI), a series of graphical user interfaces that facilitate this data pre-processing, including the removal of channel crosstalk, noise and antibody aggregates. Our software streamlines these steps and accelerates processing by enabling real-time and interactive parameter tuning across multiple images.